Advanced Enzyme Technologies Limited Share Price & Analysis
₹359.35▲ +1.61%Updated 5 May 2026, 11:31 am IST
LTP
₹359.35
+1.61%
Open
₹—
High
₹366.95
Low
₹350.1
Close
₹359.35
52W High
₹367
52W Low
₹252
Volume
255K
Lot Size
1
Sector
Healthcare
Market Cap
₹4K Cr
Face Value
₹2
Small Cap
Price Chart
Fundamentals
P/E
27
Sector P/E
39.9
P/B
2.7
EPS
₹13.61
ROE
9.54%
ROCE
13.1%
D/E Ratio
0.02
Div Yield
1.5%
Book Value
₹133
+
Strengths
- ✓Attractively valued vs sector (P/E 27x vs industry 39.9x)
- ✓Virtually debt-free
- ✓Regular dividends — yield 1.5%
−
Concerns
- ✗Trading near 52-week high (₹367)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,830 | ₹4.3L Cr | 35.8 | 5.65 | 16.9 | 20.2 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹6,641 | ₹1.7L Cr | 68.1 | 11.43 | 15.4 | 20.4 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,308 | ₹1.4L Cr | 61.4 | 17.23 | 26.5 | 27 | 0.33 |
| DRREDDY Dr. Reddy's Laboratories Limited | ₹1,281 | ₹1.1L Cr | 19.8 | 2.97 | 18 | 22.7 | 0.16 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹7,767 | ₹1.1L Cr | 60.5 | 12.29 | 18.4 | 16.6 | 0.88 |
| CIPLA Cipla Limited | ₹1,336 | ₹1.1L Cr | 22.2 | 3.28 | 17.8 | 22.7 | 0.01 |
| LUPIN Lupin Limited | ₹2,380 | ₹1.1L Cr | 21.2 | 5.54 | 20.6 | 21.3 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ADVENZYMES · as of Mar 2026
Promoters43.08%▲0.16
FII11.90%▼0.67
DII8.19%▲0.02
Public36.82%▲0.51
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 43.62% | 43.50% | 43.02% | 42.95% | 42.92% | 43.08% |
| FII | 22.54% | 23.01% | 12.03% | 12.63% | 12.57% | 11.90% |
| DII | 6.98% | 7.56% | 8.08% | 8.02% | 8.17% | 8.19% |
| Public | 26.88% | 25.95% | 36.87% | 36.40% | 36.31% | 36.82% |
Corporate Events
To consider and approve the financial results for the period ended March 31, 2026 and dividend
Dividend8 May 2026
Dividend - Rs 1.20 Per Share
Dividend22 Jul 2025
Interim Dividend - Rs 4 Per Share
Record: 16 May 2025
Dividend15 May 2025
Dividend - Re 1.1 Per Share
Dividend17 Jul 2024
Interim Dividend - Rs 4 Per Share
Record: 17 May 2024
Dividend16 May 2024
Dividend - Re 1 Per Share
Record: 4 Aug 2023
Dividend3 Aug 2023
Interim Dividend - Rs 4 Per Share
Record: 19 May 2023
Dividend18 May 2023
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹172 Cr ▼7.0% | ₹185 Cr ▼0.5% | ₹186 Cr ▲11.4% | ₹167 Cr ▼1.2% | ₹169 Cr ▲15.8% | ₹146 Cr ▼5.8% | ₹155 Cr ▼1.9% | ₹158 Cr |
| Op. Profit | ₹49 Cr ▼18.3% | ₹60 Cr ▲7.1% | ₹56 Cr ▲21.7% | ₹46 Cr ▼16.4% | ₹55 Cr ▲31.0% | ₹42 Cr ▼17.6% | ₹51 Cr ▼7.3% | ₹55 Cr |
| OPM | 29.0% ▼12.1% | 33.0% ▲10.0% | 30.0% ▲11.1% | 27.0% ▼18.2% | 33.0% ▲13.8% | 29.0% ▼12.1% | 33.0% ▼5.7% | 35.0% |
| Net Profit | ₹43 Cr ▼4.4% | ₹45 Cr ▲12.5% | ₹40 Cr ▲48.1% | ₹27 Cr ▼30.8% | ₹39 Cr ▲18.2% | ₹33 Cr ▼5.7% | ₹35 Cr ▲16.7% | ₹30 Cr |
| EPS (₹) | 3.8 ▼1.8% | 3.87 ▲8.4% | 3.57 ▲50.6% | 2.37 ▼29.7% | 3.37 ▲14.6% | 2.94 ▼3.6% | 3.05 ▲20.6% | 2.53 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹637 Cr ▲2.1% | ₹624 Cr ▲15.3% | ₹541 Cr ▲2.3% | ₹529 Cr ▲5.4% | ₹502 Cr ▲13.1% | ₹444 Cr ▲5.7% | ₹420 Cr ▲7.4% | ₹391 Cr ▲18.8% | ₹329 Cr |
| Expenses | ₹441 Cr ▲5.5% | ₹418 Cr ▲9.4% | ₹382 Cr ▲16.8% | ₹327 Cr ▲21.6% | ₹269 Cr ▲11.6% | ₹241 Cr ▲2.1% | ₹236 Cr ▲4.4% | ₹226 Cr ▲27.7% | ₹177 Cr |
| Op. Profit | ₹196 Cr ▼4.9% | ₹206 Cr ▲30.4% | ₹158 Cr ▼22.2% | ₹203 Cr ▼12.5% | ₹232 Cr ▲14.3% | ₹203 Cr ▲10.3% | ₹184 Cr ▲11.5% | ₹165 Cr ▲8.6% | ₹152 Cr |
| OPM | 31.0% ▼6.1% | 33.0% ▲13.8% | 29.0% ▼23.7% | 38.0% ▼17.4% | 46.0% ▲0.0% | 46.0% ▲4.5% | 44.0% ▲4.8% | 42.0% ▼8.7% | 46.0% |
| Other Income | ₹33 Cr ▲57.1% | ₹21 Cr ▲0.0% | ₹21 Cr ▲250.0% | ₹6 Cr ▼33.3% | ₹9 Cr ▲50.0% | ₹6 Cr ▲20.0% | ₹5 Cr ▲400.0% | ₹1 Cr ▼66.7% | ₹3 Cr |
| Interest | ₹5 Cr ▲25.0% | ₹4 Cr ▲33.3% | ₹3 Cr ▲0.0% | ₹3 Cr ▲0.0% | ₹3 Cr ▼25.0% | ₹4 Cr ▼20.0% | ₹5 Cr ▼44.4% | ₹9 Cr ▲125.0% | ₹4 Cr |
| Depreciation | ₹37 Cr ▲5.7% | ₹35 Cr ▲0.0% | ₹35 Cr ▲0.0% | ₹35 Cr ▲25.0% | ₹28 Cr ▲7.7% | ₹26 Cr ▲23.8% | ₹21 Cr ▲16.7% | ₹18 Cr ▲38.5% | ₹13 Cr |
| PBT | ₹187 Cr ▼0.5% | ₹188 Cr ▲34.3% | ₹140 Cr ▼18.1% | ₹171 Cr ▼18.6% | ₹210 Cr ▲17.3% | ₹179 Cr ▲10.5% | ₹162 Cr ▲16.5% | ₹139 Cr ▲1.5% | ₹137 Cr |
| Tax % | 28.0% ▲3.7% | 27.0% ▲3.8% | 26.0% ▼7.1% | 28.0% ▲0.0% | 28.0% ▲7.7% | 26.0% ▼7.1% | 28.0% ▼15.2% | 33.0% ▲3.1% | 32.0% |
| Net Profit | ₹134 Cr ▼2.2% | ₹137 Cr ▲31.7% | ₹104 Cr ▼16.1% | ₹124 Cr ▼17.9% | ₹151 Cr ▲13.5% | ₹133 Cr ▲14.7% | ₹116 Cr ▲23.4% | ₹94 Cr ▲1.1% | ₹93 Cr |
| EPS (₹) | 11.72 ▼1.7% | 11.92 ▲26.1% | 9.45 ▼11.7% | 10.7 ▼18.3% | 13.09 ▲13.0% | 11.58 ▲16.4% | 9.95 ▲23.3% | 8.07 ▼1.6% | 8.2 |
| Div Payout | 44.0% ▲2.3% | 43.0% ▲290.9% | 11.0% ▲22.2% | 9.0% ▲28.6% | 7.0% ▲40.0% | 5.0% ▼16.7% | 6.0% ▲0.0% | 6.0% ▲20.0% | 5.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities | ||||||||||
| Equity Capital | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr ▲0.0% | ₹22 Cr |
| Reserves | ₹1.5K Cr ▲4.6% | ₹1.4K Cr ▲7.4% | ₹1.3K Cr ▲7.3% | ₹1.2K Cr ▲13.8% | ₹1.1K Cr ▲12.4% | ₹948 Cr ▲16.0% | ₹817 Cr ▲24.4% | ₹657 Cr ▲22.3% | ₹537 Cr ▲21.5% | ₹442 Cr |
| Borrowings | ₹35 Cr ▼10.3% | ₹39 Cr ▼17.0% | ₹47 Cr ▲38.2% | ₹34 Cr ▼2.9% | ₹35 Cr ▲52.2% | ₹23 Cr ▼17.9% | ₹28 Cr ▼20.0% | ₹35 Cr ▼47.8% | ₹67 Cr ▲24.1% | ₹54 Cr |
| Other Liabilities | ₹173 Cr ▲14.6% | ₹151 Cr ▲0.7% | ₹150 Cr ▲5.6% | ₹142 Cr ▲3.6% | ₹137 Cr ▼10.5% | ₹153 Cr ▲47.1% | ₹104 Cr ▲14.3% | ₹91 Cr ▼10.8% | ₹102 Cr ▲56.9% | ₹65 Cr |
| Total Liabilities | ₹1.7K Cr ▲5.0% | ₹1.6K Cr ▲5.9% | ₹1.5K Cr ▲7.8% | ₹1.4K Cr ▲12.0% | ₹1.3K Cr ▲9.9% | ₹1.1K Cr ▲18.0% | ₹971 Cr ▲20.6% | ₹805 Cr ▲10.7% | ₹727 Cr ▲24.7% | ₹583 Cr |
| Assets | ||||||||||
| Fixed Assets | ₹683 Cr ▲0.6% | ₹679 Cr ▲4.5% | ₹650 Cr ▲0.2% | ₹649 Cr ▲4.8% | ₹619 Cr ▲3.0% | ₹601 Cr ▲6.7% | ₹563 Cr ▲13.7% | ₹495 Cr ▲0.8% | ₹491 Cr ▲16.6% | ₹421 Cr |
| CWIP | ₹31 Cr ▲40.9% | ₹22 Cr ▼46.3% | ₹41 Cr ▲86.4% | ₹22 Cr ▲46.7% | ₹15 Cr ▲50.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▲0.0% | ₹10 Cr ▼9.1% | ₹11 Cr ▲37.5% | ₹8 Cr |
| Investments | ₹529 Cr ▲10.2% | ₹480 Cr ▲19.1% | ₹403 Cr ▲11.9% | ₹360 Cr ▲252.9% | ₹102 Cr ▼15.7% | ₹121 Cr ▼2.4% | ₹124 Cr ▲11.7% | ₹111 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹449 Cr ▲4.4% | ₹430 Cr ▲0.7% | ₹427 Cr ▲12.4% | ₹380 Cr ▼27.5% | ₹524 Cr ▲26.9% | ₹413 Cr ▲50.2% | ₹275 Cr ▲46.3% | ₹188 Cr ▼16.8% | ₹226 Cr ▲47.7% | ₹153 Cr |
| Total Assets | ₹1.7K Cr ▲5.0% | ₹1.6K Cr ▲5.9% | ₹1.5K Cr ▲7.8% | ₹1.4K Cr ▲12.0% | ₹1.3K Cr ▲9.9% | ₹1.1K Cr ▲18.0% | ₹971 Cr ▲20.6% | ₹805 Cr ▲10.7% | ₹727 Cr ▲24.7% | ₹583 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹142 Cr ▲0.7% | ₹141 Cr ▲0.7% | ₹140 Cr ▲14.8% | ₹122 Cr ▼25.2% | ₹163 Cr ▲15.6% | ₹141 Cr ▲9.3% | ₹129 Cr ▲11.2% | ₹116 Cr ▲8.4% | ₹107 Cr ▲15.1% | ₹93 Cr |
| Investing CF | ₹-89 Cr ▼36.9% | ₹-65 Cr ▲77.3% | ₹-286 Cr ▼14400.0% | ₹2 Cr ▲107.4% | ₹-27 Cr ▲37.2% | ₹-43 Cr ▲65.3% | ₹-124 Cr ▼106.7% | ₹-60 Cr ▲0.0% | ₹-60 Cr ▼500.0% | ₹-10 Cr |
| Financing CF | ₹-73 Cr ▼23.7% | ₹-59 Cr ▼126.9% | ₹-26 Cr ▲45.8% | ₹-48 Cr ▼84.6% | ₹-26 Cr ▲33.3% | ₹-39 Cr ▲9.3% | ₹-43 Cr ▼2050.0% | ₹-2 Cr ▲96.9% | ₹-65 Cr ▼3.2% | ₹-63 Cr |
| Net Cash Flow | ₹-20 Cr ▼217.6% | ₹17 Cr ▲109.9% | ₹-171 Cr ▼328.0% | ₹75 Cr ▼31.2% | ₹109 Cr ▲81.7% | ₹60 Cr ▲257.9% | ₹-38 Cr ▼170.4% | ₹54 Cr ▲400.0% | ₹-18 Cr ▼185.7% | ₹21 Cr |
| Free Cash Flow | ₹108 Cr ▲14.9% | ₹94 Cr ▼7.8% | ₹102 Cr ▲7.4% | ₹95 Cr ▼33.6% | ₹143 Cr ▲58.9% | ₹90 Cr ▼22.4% | ₹116 Cr ▲10.5% | ₹105 Cr ▲8.2% | ₹97 Cr ▲10.2% | ₹88 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66d ▲13.8% | 58d ▼14.7% | 68d ▲11.5% | 61d ▼3.2% | 63d ▲3.3% | 61d ▲19.6% | 51d ▼7.3% | 55d ▲0.0% | 55d ▲5.8% | 52d |
| Inventory Days | 378d ▲0.8% | 375d ▲9.3% | 343d ▼14.7% | 402d ▲16.2% | 346d ▼4.2% | 361d ▼0.6% | 363d ▲7.1% | 339d ▼3.7% | 352d ▼1.7% | 358d |
| Days Payable | 41d ▲2.5% | 40d ▼40.3% | 67d ▲11.7% | 60d ▲7.1% | 56d ▲30.2% | 43d ▼6.5% | 46d ▼41.0% | 78d ▲36.8% | 57d ▼16.2% | 68d |
| Cash Conv. Cycle | 403d ▲2.5% | 393d ▲14.2% | 344d ▼14.9% | 404d ▲14.4% | 353d ▼6.9% | 379d ▲2.7% | 369d ▲17.1% | 315d ▼10.3% | 351d ▲2.6% | 342d |
| Working Capital Days | 112d ▲9.8% | 102d ▼6.4% | 109d ▼6.0% | 116d ▲23.4% | 94d ▲4.4% | 90d ▲25.0% | 72d ▲53.2% | 47d ▼38.2% | 76d ▲2433.3% | 3d |
| ROCE | 13.0% ▼13.3% | 15.0% ▲25.0% | 12.0% ▼25.0% | 16.0% ▼27.3% | 22.0% ▲0.0% | 22.0% ▼8.3% | 24.0% ▼4.0% | 25.0% ▼19.4% | 31.0% ▼13.9% | 36.0% |
Source: Screener.in · Lower days = better efficiency
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited is engaged in the business of manufacturing and sales of enzymes.[1]
Healthcare · Pharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Advanced Enzyme Technologies Limited share price today?▾
Advanced Enzyme Technologies Limited (ADVENZYMES) is currently trading at ₹359.35 on NSE, up 1.61% as of the last market session. Prices update daily after market close on MarketNetra.
Is Advanced Enzyme Technologies Limited available in F&O (Futures & Options)?▾
Yes, Advanced Enzyme Technologies Limited (ADVENZYMES) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Advanced Enzyme Technologies Limited 52-week high and low?▾
Advanced Enzyme Technologies Limited's 52-week high is ₹367 and the 52-week low is ₹252. The current price of ₹359.35 is 2.1% below the 52W high.
What is Advanced Enzyme Technologies Limited P/E ratio?▾
Advanced Enzyme Technologies Limited's current P/E ratio is 27. This indicates the market is paying ₹27 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Advanced Enzyme Technologies Limited options?▾
Advanced Enzyme Technologies Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ADVENZYMES options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.